A delegation of 85 global health professionals, scientists and policymakers from Harvard University’s Science of Defeating Malaria initiative has commended the establishment of the NASENI-Troment Biotechnologies factory, describing it as a significant step toward combating malaria and other infectious diseases in Nigeria and across Africa.
The team made the remarks during a tour of the multi-million-dollar facility on Sunday, June 7, 2026. Participants praised the factory’s capacity to produce Polymerase Chain Reaction (PCR) kits and Rapid Diagnostic Test (RDT) kits, noting that the project represents a major milestone in the development of a fully Nigerian-owned diagnostic brand.
Speaking during a presentation, the Chief Executive Officer and Co-Founder of NASENI-Troment Biotechnologies, Mr. Selim Hani, explained that the facility emerged from a strategic partnership between the National Agency for Science and Engineering Infrastructure (NASENI) and Troment Nigeria Limited.
According to him, the partnership seeks to strengthen Nigeria’s healthcare sovereignty through the local production of critical diagnostic technologies.
“Built from the ground up within the last 18 months, the facility focuses on the manufacturing of Rapid Diagnostic Tests and In-Vitro Diagnostic products. It enables the early detection of major infectious and public health diseases,” Hani said.
He disclosed that diagnostic kits under the N-CheckUP brand would be produced to detect diseases such as malaria, hepatitis B and C, HIV 1 and 2, pregnancy-related conditions, COVID-19, typhoid fever, syphilis and blood glucose levels.



Hani further revealed that the factory has the capacity to produce up to 600 million diagnostic kits annually, a development expected to reduce Nigeria’s dependence on imported medical diagnostics while improving affordability and accessibility across the country and the wider African region.
Also speaking, the Technical Partner of NASENI-Troment Biotechnologies, Dr. Engin Narinc, described the facility as a landmark achievement for the continent.
“This is Africa’s first fully localised Rapid Diagnostic Test kit factory. From concept development to full-scale production, our end-to-end manufacturing process is designed to deliver world-class diagnostic solutions built entirely in Africa, for Africa,” he said.
Leading the visiting delegation, Professor Dyann F. Wirth, one of the world’s foremost malaria researchers and Team Lead of the Science of Defeating Malaria Initiative at Harvard University, toured the various sections of the facility and expressed admiration for the project.
“This is an amazing facility that will contribute significantly to the eradication of malaria and other public health diseases in Nigeria and across the African continent,” she said.
The Science of Defeating Malaria leadership development programme, currently taking place in Abuja from June 7 to June 13, 2026, brings together global health professionals, scientists and policymakers committed to advancing malaria elimination and eradication efforts worldwide.
The visit underscores growing international recognition of Nigeria’s efforts to strengthen local healthcare manufacturing and reduce dependence on imported medical technologies.